THIS IS A DOCUMENT BUNDLE.
A bundle is a pre-defined set of documents. By purchasing the document bundle as a whole, you achieve significant savings from purchasing the documents individually. See full details below.
BUNDLE DESCRIPTION
As the pharma industry evolves, it's important to know you are basing your decisions on analysis that reflects the very latest trends and issues. With event-sensitive analysis, you can build your strategy based on analysis and forecasts that are reliable and accurate, to give you the tools to rapidly respond to changes across key diseases areas, companies and drugs.
Evaluate your drug's clinical and commercial potential against related treatments based on emerging clinical trial results and treatment guidelines.
Prioritize market opportunities: Assess revenue potential, competitive threats, market catalysts, and untapped product development opportunities with most up-to-date, comprehensive coverage of drugs, companies, epidemiology, diseases, strategy, and pricing and reimbursement trends.
Identify unmet needs: Gauge the relative strength of upcoming drugs with our drug comparator tool. Identify untapped opportunities.
What's Included
INTRODUCTION
1. Key Findings
2. Market Share of Drug Classes in 2015 and 2025
3. Disease Market SWOT Analysis
ETIOLOGY AND PATHOPHYSIOLOGY
1. Key Findings
2. Expert Insight
3. Disease Overview
4. Disease Pathophysiology
5. Etiology
6. Pathophysiology
KEY PATHWAYS AND DRUG TARGETS
MARKET OUTLOOK
1. Key Findings
2. Expert Insight
3. Market Overview
4. What Factors Are Driving the Market
5. What Factors Are Constraining the Market
THERE ARE 5 DOCUMENTS ARE IN THIS BUNDLE:
|
Colorectal cancer therapy market will grow modestly from $8.4 billion in 2015 to $12.5 billion in 2025 in the seven major pharmaceutical markets under study. Growth will be... [read more]
View Details
Individual Price: $99.00
|
|
In 2015, major-market sales totaled $1.2 billion for gastric and gastroesophageal junction (GEJ) adenocarcinoma. We expect that major-market sales will rapidly increase... [read more]
View Details
Individual Price: $99.00
|
|
Yielding an mPFS of 6.9 months and MOS of 14.6 months, the Stupp regimen has been the efficacy yardstick and standard treatment protocol followed for newly diagnosed... [read more]
View Details
Individual Price: $99.00
|
|
The multiple myeloma market will witness an impressive 10% annual growth over 2015-2025, with major-market sales increasing from $8.6 billion in 2015 to $22.3 billion in 2025.... [read more]
View Details
Individual Price: $99.00
|
|
The breast cancer therapy market was the largest in oncology across the major markets (United States, France, Germany, Italy, Spain, United Kingdom, and Japan) in 2015... [read more]
View Details
Individual Price: $99.00
|
Got a question about the product? Email us at [email protected] or ask the author directly by using the form to the right.
| |
Pharma Disease Insights: Oncology
Sold by BigPharma2000 (this author has 41 documents)
$495.00
(40% discount)
$299.00
ALL FEES INCLUDED
|
Add to Cart
|
This business document is categorized under the function(s):
It applies to Healthcare & Life Sciences Purchase includes lifetime product updates. After your purchase, you will receive an email to download the documents in this bundle.
Initial upload date (first version): Jun 13, 2017
Download our FREE Strategy & Transformation Framework Templates
|
Download our free compilation of 50+ Strategy & Transformation slides and templates. Frameworks include McKinsey 7-S Strategy Model, Balanced Scorecard, Disruptive Innovation, BCG Experience Curve, and many more.
To receive this free download, enter your email address below and click the "Email Me" button.
|
Ask the Author a Question
Must be logged in
Click here to log in
|